Financials
- Market Capitalization 8.64 B
- Employee 399
- Founded 1993
- CEO Michael S Weiss
- Website www.tgtherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG000FVZQY1
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
20.05
Fiyat/satışlar oranı
10.98
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 973 | CRNX Crinetics Pharmaceuticals, Inc. - Common Stock | 84.95 USD | 0.00% | +0.12% | +1.53% | +106.69% | 9.01 B USD | ||
| 986 | ABVX Abivax SA - American Depositary Shares | 112.31 USD | -1.20% | -4.69% | -6.72% | +36.33% | 8.82 B USD | ||
| 1015 | APGE Apogee Therapeutics, Inc. - Common Stock | 135.08 USD | 0.00% | +0.09% | +0.72% | +152.06% | 8.40 B USD | ||
| 1025 | IBRX ImmunityBio, Inc. - Common Stock | 7.82 USD | -0.64% | -5.10% | +8.91% | +227.20% | 8.29 B USD |